Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Dec 1;23:1176. doi: 10.1186/s12885-023-11676-7

Correction: Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner

Feng Yu 1,#, Lili Li 2,#, Mengwen Zhang 3, Shanshan Sun 4,✉
PMCID: PMC10691008  PMID: 38041002

Correction: BMC Cancer 23, 948 (2023)

https://doi.org/10.1186/s12885-023-11450-9

Following publication of the original article [1], the authors identified an error the presentation of the author affiliations. The correct affiliations are presented to in this article.

Feng Yu is affiliated to 1, Lili Li is affiliated to 2, Mengwen Zhang is affiliated to 3 and Shanshan Sun is affiliated to 4. The original article [1] has been corrected.

Footnotes

Feng Yu and Lili Li contributed equally to this study.

Reference

  • 1.Yu F, Li L, Zhang M, et al. Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. BMC Cancer. 2023;23:948. doi: 10.1186/s12885-023-11450-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES